Ionis Pharmaceuticals, Inc. (IONS)
75.13
+0.04
(+0.05%)
USD |
NASDAQ |
Apr 01, 16:00
75.11
-0.02
(-0.03%)
After-Hours: 20:00
Ionis Pharmaceuticals Research and Development Expense (TTM) : 914.12M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Biogen, Inc. | 1.498B |
| Mirum Pharmaceuticals, Inc. | 185.83M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |